Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Other Operating Expense: ¥193 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600513 Jiangsu Lianhuan Pharmaceutical Co Ltd SHSE:600513
67 GF Score
Price ¥15.65
GF Value ¥15.57
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Jiangsu Lianhuan Pharmaceutical Co Other Operating Expense?

Jiangsu Lianhuan Pharmaceutical Co SHSE:600513 -1.94% 67 Other Operating Expense is ¥193 Mil as of Jun. 2026. GuruFocus rates SHSE:600513 with a GF Score™ of 67/100 and a GF Value™ of ¥15.57 (Fairly Valued). The stock has 9 warning signs investors should review.

Jiangsu Lianhuan Pharmaceutical Co's Other Operating Expense for the three months ended in Jun. 2026 was ¥108 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥193 Mil.

Jiangsu Lianhuan Pharmaceutical Co's quarterly Other Operating Expense declined from Dec. 2025 (¥160 Mil) to Mar. 2026 (¥3 Mil) but then increased from Mar. 2026 (¥3 Mil) to Jun. 2026 (¥108 Mil).

Jiangsu Lianhuan Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2023 (¥111 Mil) to Dec. 2024 (¥130 Mil) and increased from Dec. 2024 (¥130 Mil) to Dec. 2025 (¥167 Mil).

Jiangsu Lianhuan Pharmaceutical Co Other Operating Expense Related Terms

Jiangsu Lianhuan Pharmaceutical Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Lianhuan Pharmaceutical Co Other Operating Expense Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.78 103.52 110.86 130.44 166.81

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.37 -77.99 160.00 2.59 108.08
SHSE:600513
67GF Score
Jiangsu Lianhuan Pharmaceutical Co Ltd SHSE:600513
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Lianhuan Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥193 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of ¥193 Mil mean?
Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) has a Other Operating Expense of ¥193 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors.
Is Jiangsu Lianhuan Pharmaceutical Co's Other Operating Expense too high?
Jiangsu Lianhuan Pharmaceutical Co's current Other Operating Expense is ¥193 Mil. Overall, Jiangsu Lianhuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Lianhuan Pharmaceutical Co's Other Operating Expense compare to ZTS?
Jiangsu Lianhuan Pharmaceutical Co's Other Operating Expense of ¥193 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Jiangsu Lianhuan Pharmaceutical Co and its competitors. Jiangsu Lianhuan Pharmaceutical Co's current Other Operating Expense is ¥193 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Lianhuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.57, compared to a current price of ¥15.65 — trading 0.5% above its estimated fair value. The current Other Operating Expense is ¥193 Mil. Jiangsu Lianhuan Pharmaceutical Co's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513), the current Other Operating Expense is ¥193 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Lianhuan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥15.65 is trading 0.5% above its estimated GF Value™ of ¥15.57. GuruFocus considers Jiangsu Lianhuan Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600513:

  • Other Operating Expense: ¥193 Mil
  • GF Value™: ¥15.57 vs. price of ¥15.65 (0.5% above fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the SHSE:600513 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jiangsu Lianhuan Pharmaceutical Co Business Description

Address No. 9, Jiankang 1st Road, Yangzhou Bio-Health Industry Park, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225127
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs. In the field of pharmaceutical manufacturing, the company's main products include several series such as urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics, etc., covering chemical raw materials and injections, solid preparations and various drug dosage forms, including the national first-class new drug Apelite Tablets (Chuanliu).
67GF Score

Get the complete analysis for SHSE:600513

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.65
Price
¥15.57
GF Value